PUK16 Reduced Use of Erythropoiesis-Stimulating Agents and Intravenous Iron with Use of the Phosphate Binder Ferric Citrate- a Facility-Level Cost-Offset Model Under the Medicare Bundle
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.836
https://www.valueinhealthjournal.com/article/S1098-3015(12)00901-1/fulltext
Title :
PUK16 Reduced Use of Erythropoiesis-Stimulating Agents and Intravenous Iron with Use of the Phosphate Binder Ferric Citrate- a Facility-Level Cost-Offset Model Under the Medicare Bundle
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00901-1&doi=10.1016/j.jval.2012.03.836
First page :
A155
Section Title :
Urinary/Kidney Disorders
Open access? :
No
Section Order :
322